Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012057306> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2012057306 endingPage "44" @default.
- W2012057306 startingPage "35" @default.
- W2012057306 abstract "A 49-year old male with type 2 diabetes mellitus was given 3 grams (gm) of oral arginine per hour for 10-hours, the effects on plasma glucose, insulin, C-peptide and glucose concentrations were determined. Oral arginine administration decreased plasma glucose concentrations and glucose production by approximately 40% over an 8-hr study (5%/hr). Supplemental arginine is inexpensive and may provide physicians with an additional tool in the treatment of type 2 diabetes. Six obese volunteers with type 2 diabetes were studied to document the effects of oral arginine on fasting glucose concentration and glucose production rate (GPR). Patients were admitted to the General Clinical Research Center for a 3-day stay. Oral arginine was ingested at 3-gm per hour starting at 4 am until 2 pm on day 2 or day 3 (randomized to arginine or to no-arginine supplement). Oral arginine administration was well tolerated and failed to increase C-peptide or insulin concentrations over the 10-hr period of administration. Unlike what was documented in the first diabetic patient, the prospective administration of oral arginine failed to reduce glucose concentrations (9.9 ± 1.8 vs 10.3 ± 1.8 mM) or GPR (14.7 ± 1.5 vs 15.7 ± 2.3 μmol/kg/min; arginine vs no-arginine; NS). The fall in blood glucose over the 8-hour period was not significantly increased during oral arginine administration (3.3% vs 2.6% per hour, arginine vs no-arginine, NS). These data demonstrate that 3-gm per hour of oral arginine had no effect on GPR or fasting blood glucose concentration in obese type 2 diabetic volunteers." @default.
- W2012057306 created "2016-06-24" @default.
- W2012057306 creator A5035389114 @default.
- W2012057306 creator A5072229249 @default.
- W2012057306 date "2003-01-01" @default.
- W2012057306 modified "2023-09-24" @default.
- W2012057306 title "Oral arginine has no acute effect on blood glucose concentrations or glucose production in type 2 diabetic volunteers" @default.
- W2012057306 cites W1978337405 @default.
- W2012057306 cites W2007671598 @default.
- W2012057306 cites W2036971420 @default.
- W2012057306 cites W2048574237 @default.
- W2012057306 cites W2117575518 @default.
- W2012057306 cites W2140503446 @default.
- W2012057306 cites W2141998216 @default.
- W2012057306 cites W2264438606 @default.
- W2012057306 cites W2419604885 @default.
- W2012057306 cites W4230658637 @default.
- W2012057306 doi "https://doi.org/10.1016/s0271-5317(02)00481-5" @default.
- W2012057306 hasPublicationYear "2003" @default.
- W2012057306 type Work @default.
- W2012057306 sameAs 2012057306 @default.
- W2012057306 citedByCount "2" @default.
- W2012057306 countsByYear W20120573062013 @default.
- W2012057306 crossrefType "journal-article" @default.
- W2012057306 hasAuthorship W2012057306A5035389114 @default.
- W2012057306 hasAuthorship W2012057306A5072229249 @default.
- W2012057306 hasConcept C126322002 @default.
- W2012057306 hasConcept C134018914 @default.
- W2012057306 hasConcept C185592680 @default.
- W2012057306 hasConcept C2777056448 @default.
- W2012057306 hasConcept C2777180221 @default.
- W2012057306 hasConcept C2777468819 @default.
- W2012057306 hasConcept C2779306644 @default.
- W2012057306 hasConcept C515207424 @default.
- W2012057306 hasConcept C55493867 @default.
- W2012057306 hasConcept C555293320 @default.
- W2012057306 hasConcept C71924100 @default.
- W2012057306 hasConceptScore W2012057306C126322002 @default.
- W2012057306 hasConceptScore W2012057306C134018914 @default.
- W2012057306 hasConceptScore W2012057306C185592680 @default.
- W2012057306 hasConceptScore W2012057306C2777056448 @default.
- W2012057306 hasConceptScore W2012057306C2777180221 @default.
- W2012057306 hasConceptScore W2012057306C2777468819 @default.
- W2012057306 hasConceptScore W2012057306C2779306644 @default.
- W2012057306 hasConceptScore W2012057306C515207424 @default.
- W2012057306 hasConceptScore W2012057306C55493867 @default.
- W2012057306 hasConceptScore W2012057306C555293320 @default.
- W2012057306 hasConceptScore W2012057306C71924100 @default.
- W2012057306 hasIssue "1" @default.
- W2012057306 hasLocation W20120573061 @default.
- W2012057306 hasOpenAccess W2012057306 @default.
- W2012057306 hasPrimaryLocation W20120573061 @default.
- W2012057306 hasRelatedWork W1981564790 @default.
- W2012057306 hasRelatedWork W1988703247 @default.
- W2012057306 hasRelatedWork W1991127795 @default.
- W2012057306 hasRelatedWork W2010236753 @default.
- W2012057306 hasRelatedWork W2036160461 @default.
- W2012057306 hasRelatedWork W2045993936 @default.
- W2012057306 hasRelatedWork W2059592631 @default.
- W2012057306 hasRelatedWork W2103733301 @default.
- W2012057306 hasRelatedWork W2106152476 @default.
- W2012057306 hasRelatedWork W2159347258 @default.
- W2012057306 hasVolume "23" @default.
- W2012057306 isParatext "false" @default.
- W2012057306 isRetracted "false" @default.
- W2012057306 magId "2012057306" @default.
- W2012057306 workType "article" @default.